NCT06814431View on ClinicalTrials.gov

Study on the Incidence of Malignant Neoplasms in Patients with Parkinson's Disease and Heterozygous Mutation of the GBA Gene

RecruitingOBSERVATIONAL
Enrollment

3,000

Participants

Timeline

Start Date

November 23, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

September 30, 2026

Conditions
Idiopathic Parkinson's Disease (PD)
Trial Locations (4)

42123

RECRUITING

Azienda USL IRCCS di Reggio Emilia, Reggio Emilia

Unknown

RECRUITING

Ospedale A. Perrino, Brindisi

RECRUITING

IRCCS Istituto Neurologico Carlo Besta, Milan

RECRUITING

Ospedale Santa Chiara di Trento, Trento

All Listed Sponsors
lead

Azienda USL Reggio Emilia - IRCCS

OTHER_GOV